Live feed09:26:00·336dPRReleasevia Quantisnow+2High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy HeadwindsByQuantisnow·Wall Street's wire, on your screen.ALLO· Allogene Therapeutics Inc.CATX· Perspective Therapeutics Inc.CUE· Cue Biopharma Inc.ONCY· Oncolytics Biotech Inc.VSTM· Verastem Inc.Health Care
